What Are the Signs of Richter’s Transformation?
Experts discussed the latest advances in CLL clinical trials highlighted at the 2021 American Society of Hematology (ASH) meeting, the world’s premier conference in hematology.
CLL Global Virtual Town Hall: September 12, 2024
Experts discussed the latest advances in CLL clinical trials highlighted at the 2021 American Society of Hematology (ASH) meeting, the world’s premier conference in hematology.
Chairman of the Board | What Does CLL Global Research Foundation Mean to You?
CLL Global Research Foundation’s Chairman of the Board, Steve Winfield, discusses the power of the organization and how donations are used to advance CLL research and treatments.
CLL Survivorship Begins at Diagnosis | Dr. Jackie Broadway-Duren
Dr. Jackie Broadway, a family nurse practitioner specializing in CLL, discusses the importance of survivorship care, emphasizing the necessity of managing one’s overall health after cancer.
What CLL Patients Should Know About RSV and COVID Vaccines
Experts respond to a viewer question about vaccinations for COVID and RSV as it relates to people with CLL.
Is CLL Now a Highly Treatable Condition?
Dr. William Wierda and Dr. Patrick Reville discussed the long-term treatment and management of CLL.
Understanding Data from the TRANSCEND Trial | CAR T-Cell Therapy for CLL
Experts responded to viewer questions about CAR T-cell therapy during the Feb 7, 2024 virtual town hall.
How Is CLL Treatment Guided by Cytogenetic Testing?
Experts responded to viewer questions about CLL and cytogenetic testing during the Feb 7, 2024 CLL Global Research Foundation virtual town hall.
Can Chronic Lymphocytic Leukemia (CLL) Be Inherited?
Experts responded to a viewer question about familial CLL during the Feb 7, 2024 CLL Global Research Foundation virtual town hall.
What’s Vital to Understand About MRD Status in CLL?
Experts responded to a viewer question about minimal residual disease during the Feb 7, 2024 CLL Global Research Foundation virtual town hall.